Sir,
Pyoderma gangrenosum (PG) is a sterile neutrophilic disorder that rarely affects children [
We report the case of a 12-year-old child, with no particular antecedent, who consulted for multiple painful and ulcerative lesions evolving for 8 months, he was initially treated for presumed bacterial and viral infections with oral antibiotics and antivirals, with no response.
Physical examination revealed 2 small ulcers and 3 large ulcers measuring 3 to 8 cm with irregular borders, undermined edges and indurated base following a linear distribution along the right leg (
Right leg’s ulcerations.
There was no lymphadenopathy. Hematological and biochemical examination did not reveal any abnormality.
Biopsy was performed from the ulcer edge for histopathologic evaluation and tissue cultures for bacteria, fungi, and atypical mycobacteria.
The histological examination revealed A moderately dense superficial and deep lymphoplasmocytic infiltrate around the vessels (
Dense superficial and deep lymphoplasmocytic infiltrate around the vessels with vasculitis. HEx20.
Pyoderma gangrenosum is relatively rare in the pediatric population with only 4% of PG occurring in children.
The most common presentation of PG in children is disseminated ulcerative lesions with lower extremities most frequently affected when lesions are localized [
The cause of PG is unknown, but some studies have suggested that abnormal neutrophil chemotaxis is the primary process.
PG is an inflammatory condition of the skin first described by Brunsting and colleagues in 1930. PG begins as a pustule or vesiculopustule that progresses to an ulcer or deep erosion with violaceous overhanging or undermined borders [
In adults, an associated pathology is present in 74% of cases including a chronic inflammatory bowel disease, hemopathy or rheumatoid arthritis.
While in children, pyoderma gangrenosum is idiopathic in 50% of cases.
Our patient had no associated pathology.
The sporotrichoid character has never been described before, it may be explained in our patient by repeated trauma.
Optimal treatment for infantile PG is not established due to disease rarity and paucity of data. Treatment is based on systemic corticosteroids. In case of corticoresistance, the use of other immunosuppressors could be effective.